Title : Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.

Pub. Date : 2005 Jun

PMID : 15915024






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase. Mivacurium butyrylcholinesterase Homo sapiens
2 BACKGROUND: In patients homozygous for atypical plasma cholinesterase, mivacurium causes a long-lasting neuromuscular block, but injection of human cholinesterase has been proven effective in antagonizing the block. Mivacurium butyrylcholinesterase Homo sapiens
3 Cholinesterase, 2.8-10.0 mg/kg, was administered approximately 30 or 120 min after mivacurium. Mivacurium butyrylcholinesterase Homo sapiens
4 Injection of cholinesterase significantly increases the metabolism of mivacurium, leading to a shorter duration of action. Mivacurium butyrylcholinesterase Homo sapiens